Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Immatics NV
(NQ:
IMTX
)
10.93
-0.28 (-2.50%)
Streaming Delayed Price
Updated: 11:25 AM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
45,526
Open
11.21
Bid (Size)
10.86 (3)
Ask (Size)
10.92 (4)
Prev. Close
11.21
Today's Range
10.87 - 11.27
52wk Range
7.150 - 13.77
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Biotech Stocks : Are You A Trader Or A Longer Term Investor?
October 01, 2024
Biotech bull market is intact as indicated by large cap biopharma and the best performing funds.
Via
Talk Markets
Immatics Presents Clinical Proof-of-Concept Data from Ongoing Phase 1 Dose Escalation Trial with TCR Bispecific Molecule TCER® IMA401 Targeting MAGEA4/8 at ESMO 2024 and Provides Development Update
September 16, 2024
From
https://immatics.com/
Via
GlobeNewswire
Performance
YTD
+1.96%
+1.96%
1 Month
-1.09%
-1.09%
3 Month
-9.07%
-9.07%
6 Month
+1.86%
+1.86%
1 Year
+1.30%
+1.30%
More News
Read More
Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024
September 06, 2024
From
https://immatics.com/
Via
GlobeNewswire
Why Immatics Shares Are Rising Today
July 24, 2023
Via
Benzinga
IMTX Stock Earnings: Immatics Beats EPS, Beats Revenue for Q2 2024
August 13, 2024
Via
InvestorPlace
Immatics Announces Second Quarter 2024 Financial Results and Business Update
August 13, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Appoints Alise Reicin to Board of Directors
July 31, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Upcoming Oral Presentation at ESMO Congress 2024
July 18, 2024
From
https://immatics.com/
Via
GlobeNewswire
Trading SMID Biotech Stocks In A Volatile Market
July 01, 2024
Via
Talk Markets
12 Health Care Stocks Moving In Friday's Intraday Session
May 24, 2024
Via
Benzinga
Immatics Announces First Quarter 2024 Financial Results and Business Update
May 14, 2024
From
https://immatics.com/
Via
GlobeNewswire
IMTX Stock Earnings: Immatics Beats EPS, Beats Revenue for Q4 2023
March 21, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 21, 2024
Via
Benzinga
Immatics Announces Full Year 2023 Financial Results and Corporate Update
March 21, 2024
From
https://immatics.com/
Via
GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
March 18, 2024
Via
Benzinga
Immatics Announces Pricing of $175 Million Public Offering
January 17, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Proposed Public Offering
January 17, 2024
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Third Quarter 2023 Financial Results and Business Update
November 14, 2023
From
https://immatics.com/
Via
GlobeNewswire
Immatics Reports Interim Clinical Data from ACTengine® IMA203 and IMA203CD8 TCR-T Monotherapies Targeting PRAME in an Ongoing Phase 1 Trial
November 08, 2023
From
https://immatics.com/
Via
GlobeNewswire
Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ACTengine® IMA203 TCR-T Monotherapy
October 24, 2023
From
https://immatics.com/
Via
GlobeNewswire
Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
September 11, 2023
Via
ACCESSWIRE
Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
September 11, 2023
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces Second Quarter 2023 Financial Results and Business Update
August 17, 2023
From
https://immatics.com/
Via
GlobeNewswire
Immatics Initiates Phase 1/2 Clinical Trial to Evaluate PRAME TCR Bispecific IMA402 in Patients with Advanced Solid Tumors
August 10, 2023
From
https://immatics.com/
Via
GlobeNewswire
Immatics Announces $35 Million Equity Investment from Bristol Myers Squibb
July 24, 2023
From
https://immatics.com/
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.